DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Why A Bristol-Myers Squibb Bid On Celgene Is Plausible

Bristol wins EU green light for immune system cancer drug

Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog

June 5th Options Now Available For Bristol-Myers Squibb

IHE, MRK, BMY, LLY: Large Inflows Detected at ETF

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline

Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?

Immuno-oncology has become a major focus among big pharma companies these days. Should investors jump on this trend?

Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog

Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog
See More Articles...